NIH-funded research R01 grant

Creating vaccines to protect against various coronaviruses

Official title: Development of pan-betacoronavirus vaccines

Funded at University of Pennsylvania · NIH-11042228 · Data updated 2026-11-12

This study is working on creating vaccines that help your body build strong defenses against various coronaviruses, including those that have caused recent outbreaks, so we can be better prepared for any future infections.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startMarch 3, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$709,989
NIH project number5R01AI170928-03
Project IDNIH-11042228 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who are at risk of exposure to coronaviruses or those who have had previous infections.

Less likely to help

Patients who are not at risk for coronavirus infections or those who have already been vaccinated against all known variants may not benefit from this research.

What this research studies

This research focuses on developing vaccines that can generate strong immune responses against different types of coronaviruses, including those that have caused recent pandemics. The approach involves identifying specific sites on the virus that can trigger the production of neutralizing antibodies, which are crucial for preventing infections. By using a rational vaccine design strategy, the researchers aim to create immunogens that can effectively stimulate the immune system to produce long-lasting protection against a range of coronaviruses. This work is essential for preparing for potential future outbreaks.

Why it matters

Potential benefit: If successful, this research could lead to vaccines that provide broad protection against multiple coronaviruses, potentially preventing future pandemics.

How similar studies have gone: Other research has shown promise in developing vaccines targeting coronaviruses, indicating that this approach has potential for success.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Andrabi, Raiees Ahmad — University of Pennsylvania
  • Study coordinator: Andrabi, Raiees Ahmad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.